US 9180097
Formulations of 6-mercaptopurine
granted A61KA61K31/52A61K31/522
Quick answer
US patent 9180097 (Formulations of 6-mercaptopurine) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/52, A61K31/522, A61K9/1617, A61K9/1623